FOXO TECHNOLOGIES INC. ANNOUNCES THAT ITS COMMON STOCK CAN BE QUOTED AND TRADED ON THE OVER THE COUNTER MARKET FROM AUGUST 13, 2025.

Core Viewpoint - FOXO Technologies Inc. has received a notice from NYSE regarding the delisting of its Class A common stock due to the share price falling below the minimum requirement of $0.10, leading to immediate suspension of trading [1][2]. Company Actions - The company has applied for its common stock to be traded on the OTC market and received confirmation from FINRA that the trading symbol "FOXO" has been assigned for this purpose, effective August 13, 2025 [2]. - The CEO of FOXO expressed disappointment over the share price decline but reaffirmed the company's commitment to its business strategy and growth initiatives, including potential acquisitions [3]. Company Overview - FOXO operates three subsidiaries: - Rennova Community Health, Inc., which manages a critical access hospital in East Tennessee [4]. - Myrtle Recovery Centers, Inc., a behavioral health facility providing various treatment services [4]. - FOXO Labs, Inc., focused on biotechnology and health improvement through innovative technology [5].